. Author manuscript; available in PMC: 2020 Jul 1.

Published in final edited form as: Fam Cancer. 2019 Jul;18(3):317–325. doi: 10.1007/s10689-019-00123-x

Table 2.

Patients with a molecular diagnosis of LS in MMR genes MLH1, MLH2, MLH6, and PMS2 among those who underwent germline testing in the Intervention arm (N=170) and among those with prior LS diagnosis or screening (N=63). No LS cases were identified in the Usual Care (N=43) or Study Decliner (N=148) arms.

Number of patients with a pathogenic variant who underwent germline testing
MMR gene	Intervention (N=14)	Prior LS diagnosis or screening (N=16)
*MLH1*	1	2
*MSH2*	1	4
*MSH6*	1	1
*PMS2*	3	2
No pathogenic variant	8	7